« Back to Intelligence Feed Amplifon to Buy GN Store Nord Hearing Aid Unit for $2.6 Billion

Amplifon to Buy GN Store Nord Hearing Aid Unit for $2.6 Billion

ABI Analysis · Pan-African health Sentiment: 0.70 (positive) · 16/03/2026
Italy-headquartered Amplifon has secured a transformative acquisition, agreeing to purchase GN Store Nord's hearing aid division for $2.6 billion (approximately €2.4 billion), in a move that fundamentally reshapes the competitive landscape of Europe's audiology sector. The transaction represents one of the largest healthcare technology consolidations of the year and signals accelerating consolidation within a fragmented but rapidly professionalizing market. GN Store Nord's hearing business, which operates under the ReSound brand, generated substantial revenues and commanded significant market share across Nordic and Northern European territories. For Amplifon, a Milan-based hearing care leader already operating across 26 countries with over 6,000 retail locations, this acquisition substantially amplifies its product portfolio, distribution network, and technological capabilities in digital hearing solutions. The broader context illuminates why this deal matters for European investors. Europe's hearing aid market remains substantially underpenetrated—an estimated 72 million people across the continent experience hearing loss, yet fewer than one in three seek treatment. This treatment gap creates significant runway for market growth. The global hearing aid market is projected to reach $13.6 billion by 2030, growing at 5.4% annually, driven by aging demographics, increasing smartphone integration, and improving reimbursement policies across European healthcare systems. For European investors, Amplifon's strategic positioning

Continue reading this analysis

Become an ABI Supporter to unlock all articles, reports and investment opportunities.

Subscribe — €10/year

Already a member? Log in

Gateway Intelligence
European investors should monitor Amplifon's integration execution closely—the real value creation depends entirely on whether the company successfully cross-sells ReSound's premium technology across its 6,000+ retail locations. Simultaneously, watch for potential divestitures of redundant ReSound retail locations in Amplifon-saturated markets, which could represent attractive acquisition targets for regional operators. Key risk: regulatory challenges in Nordic markets could force asset divestitures, creating both investment risks and opportunistic buyout openings for well-capitalized regional players.

Subscribe to read the full Gateway Intelligence insight

Unlock Full Access — €10/year

Sources: Bloomberg Africa

More health Intelligence

🇿🇦 'It's adrenaline': Ukraine amputee veterans climb for recovery

South Africa·16/03/2026

🇿🇦 KZN doctors perform world-class treatment

South Africa·16/03/2026

🇰🇪 Medics condemn arrest of Nairobi Hospital Board Chair

Kenya·16/03/2026